Sort
40,608 grants matching “prostate cancer”
Angiotensin II Receptors And Signaling Mechanisms
$620,007Kevin J Catt · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD
Hybrid Nanoparticles in Imaging and Therapy of Prostate*
$619,998University Of Missouri-Columbia · R01 · FY2005 · CA
ProstaFluor FDA Trial for Real-Time Margin Detection During Prostatectomy
$619,976David A. Benaron · Spectros Corporation · R01 · FY2011 · CA
Computational Feature Profiling and Modeling for Prostate Cancer Detection and Risk Stratification
$619,960Corey Wells Arnold · University Of California Los Angeles · R01 · FY2025 · CA
Germline modifiers of tumor progression and metastasis in prostate cancer
$619,947Nigel Crawford · National Human Genome Research Institute · ZIA · FY2014 · HG
Adaptive Percutaneous Prostate Interventions using Sensorized Needle
$619,896Junichi Tokuda · Brigham And Women'S Hospital · R01 · FY2025 · CA
Histopathology Core
$619,876David Schneeweis · National Eye Institute · ZIC · FY2019 · EY
SPORE IN PROSTATE CANCER
$619,876Johns Hopkins University · P50 · FY2003 · CA
A FORWARD GENETIC SCREENING FOR PROSTATE CANCER PROGRESSION GENES
$619,873The Geneva Foundation · · FY2011 · Department of Defense
Multichannel Fluorescence Guided Surgery Tools Enabling Simultaneous Cancer Margin and Nerve Visualization in Prostatectomy
$619,777Summer Lynne Gibbs · Oregon Health & Science University · R01 · FY2025 · CA
Staying Strong and Healthy during Androgen Deprivation Therapy for Latino Men
$619,775Sally L Maliski · University Of California Los Angeles · R01 · FY2015 · NR
Targeting B7-H3 in ovarian cancer
$619,664Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Transcriptome-wide association study to identify susceptibility genes for colorectal cancer
$619,625Xingyi Guo · Vanderbilt University Medical Center · R37 · FY2018 · CA
Georgia CaRes
$619,518Sharad A. Ghamande · Augusta University · UG1 · FY2015 · CA
Novel Hyperpolarized MR Markers of Advanced Prostate Cancer Therapy
$619,505John Kurhanewicz · University Of California, San Francisco · R01 · FY2015 · CA
Software to facilitate multimode, multiscale fused data for Pathology and Radiolo
$619,383Michael D Feldman · University Of Pennsylvania · R01 · FY2012 · CA
Inflammation and Colorectal Neoplasia
$619,243Andrew T Chan · Massachusetts General Hospital · R01 · FY2019 · CA
TREATMENT DECISIONS AND PATIENT REPORTED OUTCOMES IN LOW RISK PROSTATE CANCER
$619,221Kathryn L Taylor · Georgetown University · R01 · FY2012 · CA
Effect of Aerobic Exercise on Genomic Signatures of Prostate Cancer Prognosis
$619,068June Ml Chan · University Of California, San Francisco · R01 · FY2018 · CA
Studies of Proteins with Important Roles in Immunology andor Cancer Biology
$619,065Jacek T Lubkowski · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
IDENTIFICATION AND VALIDATION OF SMALL MOLECULE WNT ANTAGONISTS AS POTENTIAL THERAPEUTICS FOR TREATING PROSTATE CANCER
$619,057Yale Univ · · FY2008 · Department of Defense
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
$618,976Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
LIGHTING-UP PROSTATE CANCER FOR IMMUNOTHERAPY
$618,750University Of Southern California · · FY2015 · Department of the Army
Clinical Pharmacogenetics
$618,723William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents
$618,723William Douglas Figg · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA